DMJ-I-228
CAS No. 1374035-59-2
DMJ-I-228 ( +)-DMJ-I-228 )
Catalog No. M11542 CAS No. 1374035-59-2
A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDMJ-I-228
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
-
DescriptionA small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
-
Synonyms+)-DMJ-I-228
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1374035-59-2
-
Formula Weight435.84
-
Molecular FormulaC19H19ClFN5O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(Cl)C(F)=C1)C(N[C@@H]2[C@@H](NC(N)=N)CC3=C2C=CC=C3)=O.O=CO
-
Chemical NameN1-(4-chloro-3-fluorophenyl)-N2-((1S,2S)-2-guanidino-2,3-dihydro-1H-inden-1-yl)oxalamide formate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Madani N, et al. Structure. 2008 Nov 12; 16(11):1689-701.
2. Richard J, et al. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94.
3. LaLonde JM, et al. J Med Chem. 2012 May 10;55(9):4382-96.
2. Richard J, et al. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94.
3. LaLonde JM, et al. J Med Chem. 2012 May 10;55(9):4382-96.
molnova catalog
related products
-
Doravirine
Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.
-
Ginsenoside Z-R1
Zingibroside R1 has anti-HIV-1 activity.
-
Diphyllin
Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.